James Jones resigned as FDA deputy commissioner and said the Trump administration's "indiscriminate" job cuts show "disdain for the very people necessary to implement your agenda." ...
On The Readout LOUD this week, STAT reporters discuss the FDA's staff cuts, how next-gen drugs may lead to too much weight ...
On Thursday night Judge Amir H. Ali of the U.S. District Court for the District of Columbia denied a motion to hold the Trump ...
We still don’t know the full extent of layoffs at the FDA, though they are widespread. That could reduce oversight of the ...
In his resignation letter, obtained by Bloomberg News, Jones cited “indiscriminate” layoffs to 89 staff members, including ...
1d
Hosted on MSNUS: FDA’s food chief resigns, citing job cuts, policy challengesJim Jones, the head of the food division in the United States Food and Drug Administration (FDA), resigned on Monday, citing widespread layoffs that he said would make it difficult to implement ...
For far too long, we Americans have allowed the so-called government to trample our God-given right to eat food that might ...
It has been increasingly clear … the Trump administration’s disdain for the very people necessary to implement your agenda,’ ...
Jim Jones, the head of the food division at the US Food and Drug Administration who oversaw the agency’s banning of the food ...
Jackson 1 upheld a doctor’s conviction under Section 301(k) of the Federal Food, Drug ... 1006 “practice of medicine” defense. With DOJ and FDA now armed with two circuit opinions (Kaplan ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...
Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Axsome Therapeutics' (AXSM.O), opens new tab migraine treatment, the company said on Thursday. The oral drug, branded Symbravo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results